X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-10 | IRWD | McCourt Thomas A | CEO | S - Sale | $1.76 | -139,064 | 1,160,634 | -11% | -$244,753 | ||||||
2025-02-10 | IRWD | Silver Ronald | Principal Accounting Officer | S - Sale | $1.76 | -12,048 | 279,655 | -4% | -$21,204 | ||||||
2025-02-10 | IRWD | Shetzline Michael | SVP, CMO, Head-Res, Drug | S - Sale | $1.76 | -41,269 | 554,007 | -7% | -$72,633 | ||||||
2025-02-10 | IRWD | John Minardo | GC | S - Sale | $1.76 | -38,938 | 408,132 | -9% | -$68,531 | ||||||
2025-02-10 | IRWD | Martini Gregory S. | CFO | S - Sale | $1.76 | -12,052 | 183,810 | -6% | -$21,212 | ||||||
2024-11-18 | IRWD | Davis Andrew | SVP, Chief Business Officer | S - Sale | $4.08 | -5,360 | 284,685 | -2% | -$21,869 | ||||||
2024-11-18 | IRWD | Emany Sravan Kumar | SVP, COO, CFO | S - Sale | $4.08 | -11,001 | 309,572 | -3% | -$44,884 | ||||||
2024-08-12 | IRWD | John Minardo | GC | S - Sale | $4.27 | -9,910 | 284,661 | -3% | -$42,316 | ||||||
2024-08-12 | IRWD | Silver Ronald | Principal Accounting Officer | S - Sale | $4.27 | -3,107 | 158,370 | -2% | -$13,267 | ||||||
2024-06-10 | IRWD | McHugh Julie | Dir | S - Sale | $6.29 | -22,766 | 139,528 | -14% | -$143,198 | ||||||
| M | 2024-06-06 | IRWD | Moukheibir Catherine | Dir | S - Sale | $6.47 | -80,000 | 48,633 | -62% | -$517,694 | |||||
2024-05-20 | IRWD | McCourt Thomas A | CEO | S - Sale | $6.45 | -67,618 | 1,150,330 | -6% | -$436,136 | ||||||
2024-05-20 | IRWD | Davis Andrew | SVP, Chief Business Officer | S - Sale | $6.45 | -22,725 | 288,031 | -7% | -$146,576 | ||||||
2024-05-20 | IRWD | Shetzline Michael | CMO,SVP,Head-Res, Drug | S - Sale | $6.45 | -16,128 | 413,719 | -4% | -$104,026 | ||||||
2024-05-20 | IRWD | John Minardo | GC | S - Sale | $6.45 | -17,404 | 294,571 | -6% | -$112,256 | ||||||
2024-03-06 | IRWD | Duane Jon R | Dir | P - Purchase | $8.70 | +6,920 | 121,028 | +6% | +$60,204 | ||||||
2024-03-04 | IRWD | Emany Sravan Kumar | SVP, CFO | P - Purchase | $9.38 | +10,684 | 301,733 | +4% | +$100,216 | ||||||
| D | 2024-02-12 | IRWD | John Minardo | GC | S - Sale+OE | $15.24 | -47,380 | 279,223 | -15% | -$722,071 | |||||
| D | 2024-02-12 | IRWD | Shetzline Michael | CMO,SVP,Head-Res, Drug | S - Sale+OE | $15.24 | -38,618 | 394,911 | -9% | -$588,538 | |||||
2024-02-12 | IRWD | Silver Ronald | Principal Accounting Officer | S - Sale | $15.24 | -7,908 | 161,477 | -5% | -$120,518 | ||||||
| D | 2024-02-12 | IRWD | Davis Andrew | SVP, Chief Business Officer | S - Sale+OE | $15.24 | -9,846 | 273,636 | -3% | -$150,053 | |||||
2024-02-12 | IRWD | McCourt Thomas A | CEO | S - Sale | $15.24 | -177,164 | 832,774 | -18% | -$2,699,979 | ||||||
2023-12-14 | IRWD | Kessler Marla L | Dir | S - Sale | $11.19 | -9,926 | 96,572 | -9% | -$111,072 | ||||||
2023-11-20 | IRWD | Davis Andrew | SVP, Chief Business Officer | S - Sale | $9.69 | -3,287 | 217,374 | -1% | -$31,851 | ||||||
2023-09-15 | IRWD | Emany Sravan Kumar | SVP, CFO | P - Purchase | $8.32 | +36,072 | 188,730 | +24% | +$300,119 | ||||||
2023-08-14 | IRWD | Silver Ronald | Principal Accounting Officer | S - Sale | $10.04 | -1,976 | 134,172 | -1% | -$19,839 | ||||||
2023-08-14 | IRWD | John Minardo | GC | S - Sale | $10.04 | -7,045 | 192,195 | -4% | -$70,732 | ||||||
2023-05-30 | IRWD | McCourt Thomas A | CEO | S - Sale | $10.70 | -26,632 | 758,284 | -3% | -$284,962 | ||||||
2023-05-22 | IRWD | Shetzline Michael | CMO,SVP,Head-Res, Drug | S - Sale | $10.12 | -10,324 | 321,131 | -3% | -$104,479 | ||||||
2023-05-22 | IRWD | Davis Andrew | SVP, Chief Business Officer | S - Sale | $10.12 | -6,305 | 219,327 | -3% | -$63,807 | ||||||
2023-05-22 | IRWD | McCourt Thomas A | CEO | S - Sale | $10.12 | -36,000 | 784,916 | -4% | -$364,320 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |